IP Library Granted Patent US 8,926,644
Granted Patent B2
US 8,926,644 · App. 13/261,153 · Granted Jan 6, 2015

Lancing device having saddle-shaped tip

Inventors: David Schiff (Highland Park, NJ); Akilesh Sridharan (Los Angeles, CA); Jonathan D. Albert (Philadelphia, PA)
Assignee: Becton, Dickinson and Company
A61B5/1411A61B5/150022A61B5/150259A61B5/150183A61B5/1519A61B5/157A61B5/15113A61B5/150503A61B5/150633A61B5/15142A61B5/150068A61B5/15105A61B5/150412
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,926,644
App. No.
13/261,153
Granted
Jan 6, 2015
Kind
B2
Abstract

A tip ( 41 ) for use with a lancing device ( 11 ). A wall extends upwardly from a base and forms a substantially saddle-shaped distal surface for interfacing with a patient's skin. An opening ( 43 ) extends entirely through the tip. The tip ( 41 ) is movably received by a pressure sleeve assembly. The pressure sleeve assembly includes a housing ( 37 ) and a pressure sleeve movable between first and second positions. A spring ( 35 ) is connected between the housing ( 37 ) and the pressure sleeve. A lancet ( 21 ) is rigidly fixed to the housing ( 37 ) and is covered when the pressure sleeve is in the first position and exposed through the substantially saddle-shaped distal surface ( 42 ) of the tip ( 41 ) when the pressure sleeve is in the second position. The substantially saddleshaped distal surface ( 42 ) gathers the patient's skin toward the center of the tip to facilitate expressing blood from a lanced site.

Claims (45)

1. A tip for use with a lancing device, comprising:

a base having an outer perimeter;

a wall extending upwardly from said base and forming a substantially saddle-shaped distal surface for interfacing with a patient's skin, said distal surface has a minor saddle angle between approximately 15 and 20 degrees, inclusive and a major saddle angle between approximately 45 and 60 degrees, inclusive;

an opening extending entirely through said tip, and

a lancet positioned within said opening for lancing the patient's skin.

2. The saddle-shaped tip according to claim 1 , wherein

said opening is substantially circular.

3. The saddle-shaped tip according to claim 1 , wherein

said opening is substantially oval.

4. The saddle-shaped tip according to claim 1 , wherein

said outer perimeter is substantially circular.

5. The saddle-shaped tip according to claim 1 , wherein

said outer perimeter is substantially oval.

6. A lancing device, comprising:

a tip having a substantially saddle-shaped distal surface for interfacing with a patient's skin, said distal surface having a minor saddle angle between approximately 15 and 20 degrees inclusive, and a major saddle angle between approximately 45 and 60 degrees inclusive; and

a pressure sleeve assembly movably receiving said tip, said pressure sleeve assembly including

a housing;

a pressure sleeve movable between first and second positions;

a spring connected between said housing and said pressure sleeve; and

a lancet rigidly fixed to said housing, said lancet being covered when said pressure sleeve is in said first position and said lancet being exposed through said substantially saddle-shaped distal surface of said tip when said pressure sleeve is in said second position.

7. The lancing device according to claim 6 , wherein

said tip is connected to said pressure sleeve such that movement of said tip moves said pressure sleeve.

8. The lancing device according to claim 6 , wherein

said lancet is removably connected to said housing.

9. The lancing device according to claim 6 , wherein

said spring returns said pressure sleeve to said first position.

10. The lancing device according to claim 6 , wherein

an oval opening is formed in said tip through which said lancet passes.

11. The lancing device according to claim 6 , wherein

a circular opening is formed in said tip through which said lancet passes.

12. The lancing device according to claim 6 , wherein

said lancing device is received by a glucose monitoring device.

13. The lancing device according to claim 6 , wherein

said distal surface has a circular cross section.

14. The lancing device according to claim 6 , wherein

said distal surface has an oval cross section.

15. The lancing device according to claim 6 , wherein

said housing a substantially planar surface opposite said tip for providing stability to said lancing device when applying pressure to said tip.

16. A method of drawing blood, comprising the steps of

interfacing a distal surface of a tip of a lancing device with a patient's skin at a lancing site, the distal surface of the tip being substantially saddle-shaped said distal surface having a minor saddle angle between approximately 15 and 20 degrees inclusive, and a major saddle angle between approximately 45 and 60 degrees inclusive; and

passing a needle through the saddle-shaped distal surface of the tip to lance the patient's skin at the lancing site.

17. A method of drawing blood according to claim 16 , further comprising

applying pressure to the tip to pass the needle through the saddle-shaped distal surface of the tip to lance the patient's skin at the lancing site.

18. A method of drawing blood according to claim 16 , further comprising

activating a trigger mechanism to pass the needle through the saddle-shaped distal surface of the tip to lance the patient's skin at the lancing site.

Assignments (5)
FIRST LIEN PATENT SECURITY AGREEMENT (SENIOR SECURED NOTES) Recorded Mar 14, 2023
From: EMBECTA CORP.
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT
Reel/Frame 063083/0071 →
FIRST LIEN PATENT SECURITY AGREEMENT (SENIOR SECURED NOTES) Recorded Mar 13, 2023
From: EMBECTA CORP.
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT
Reel/Frame 063780/0053 →
FIRST LIEN TERM PATENT SECURITY AGREEMENT Recorded Mar 10, 2023
From: EMBECTA CORP.
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 063028/0318 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2022
From: BECTON, DICKINSON AND COMPANY
To: EMBECTA CORP.
Reel/Frame 059721/0617 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2012
From: SCHIFF, DAVID; SRIDHARAN, AKILESH; ALBERT, JONATHAN
To: BECTON, DICKINSON AND COMPANY
Reel/Frame 028269/0416 →
Continuity (2)
Provisional Application 61213936 · Jul 30, 2009
Related Publication 20120226123A1 · Sep 6, 2012